Borrelia burgdorferi Johnson et al. emend. Baranton et al. (ATCC® 55131)

Strain Designations: HB19M  /  Type Strain: no  /  Biosafety Level: 2

Permits And Restrictions

View Permits

Strain Designations HB19M
Application
Used to produce vaccine against Lyme disease
Emerging infectious disease research
Vector borne research
Isolation
Blood - human
Belgium
Type Strain no
Biosafety Level 2

Biosafety  classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.

Product Format frozen
Preceptrol® no
Type Strain no
Comments
Flagella-less mutant
Growth Conditions
Temperature: 37.0°C
Atmosphere: Aerobic
Name of Depositor AG Barbour
U.S. Patent Number
Disclosure This material is cited in a US or other Patent and may not be used to infringe the claims. Depending on the wishes of the Depositor, ATCC may be required to inform the Patent Depositor of the party to which the material was furnished.
Isolation
Blood - human
Belgium
References

Barbour AG, Bundoc V. Flagella-less borrelia. US Patent 5,436,000 dated Jul 25 1995

human blood

Notice: Necessary PermitsPermits

These permits may be required for shipping this product:

  • Customers located in the state of Hawaii will need to contact the Hawaii Department of Agriculture to determine if an Import Permit is required. A copy of the permit or documentation that a permit is not required must be sent to ATCC in advance of shipment.
Basic Documentation